Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
作者： Stephen A. Boorjian , R. Jeffrey Karnes , Laureano J. Rangel , Eric J. Bergstralh , Michael L. Blute
DOI: 10.1016/J.JURO.2007.11.061
关键词:
摘要: Purpose: The D’Amico risk group classification was originally developed to estimate the of biochemical recurrence following treatment for localized prostate cancer. We externally validated ability groups predict clinical progression, and cancer specific overall survival radical prostatectomy, identify predictors outcome in patients with high disease.Materials Methods: evaluated records 7,591 consecutive who underwent prostatectomy at our institution between 1987 2003. Postoperative estimated using Kaplan-Meier method. Cox proportional hazard regression models were used analyze evaluate impact clinicopathological factors on risk.Results: Preoperative stratification predicted patient local recurrence, systemic (each p <0....
elsevier.com
jurology.com 参考文章(21)
M. Manoharan, V.G. Bird, S.S. Kim, F. Civantos, M.S. Soloway, Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8 BJUI. ,vol. 92, pp. 539- 544 ,(2003) , 10.1046/J.1464-410X.2003.04419.X
MICHAEL L. BLUTE, ERIK J. BERGSTRALH, ANGELO IOCCA, BETH SCHERER, HORST ZINCKE, Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. The Journal of Urology. ,vol. 165, pp. 119- 125 ,(2001) , 10.1097/00005392-200101000-00030
R. Houston Thompson, Michael L. Blute, Jeffrey M. Slezak, Eric J. Bergstralh, Bradley C. Leibovich, Is the GPSM Scoring Algorithm for Patients With Prostate Cancer Valid in the Contemporary Era The Journal of Urology. ,vol. 178, pp. 459- 463 ,(2007) , 10.1016/J.JURO.2007.03.124
John F. Ward, Jeffrey M. Slezak, Michael L. Blute, Erik J. Bergstralh, Horst Zincke, Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome BJUI. ,vol. 95, pp. 751- 756 ,(2005) , 10.1111/J.1464-410X.2005.05394.X
MAXWELL V. MENG, ERIC P. ELKIN, DAVID M. LATINI, JANEEN DuCHANE, PETER R. CARROLL, TREATMENT OF PATIENTS WITH HIGH RISK LOCALIZED PROSTATE CANCER: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CaPSURE) The Journal of Urology. ,vol. 173, pp. 1557- 1561 ,(2005) , 10.1097/01.JU.0000154610.81916.81
JOHN F. WARD, MICHAEL L. BLUTE, JEFFREY SLEZAK, ERIK J. BERGSTRALH, HORST ZINCKE, The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy The Journal of Urology. ,vol. 170, pp. 1872- 1876 ,(2003) , 10.1097/01.JU.0000091876.13656.2E
MATTHEW R. COOPERBERG, DEBORAH P. LUBECK, SHILPA S. MEHTA, PETER R. CARROLL, Time Trends in Clinical Risk Stratification for Prostate Cancer: Implications for Outcomes (Data From CaPSURE) The Journal of Urology. ,vol. 170, ,(2003) , 10.1097/01.JU.0000095025.03331.C6
Nancy L. Keating, A. James O'Malley, Matthew R. Smith, Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer Journal of Clinical Oncology. ,vol. 24, pp. 4448- 4456 ,(2006) , 10.1200/JCO.2006.06.2497
KIMBERLY A. ROEHL, MISOP HAN, CHRISTIAN G. RAMOS, JO ANN V. ANTENOR, WILLIAM J. CATALONA, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS The Journal of Urology. ,vol. 172, pp. 910- 914 ,(2004) , 10.1097/01.JU.0000134888.22332.BB
Anthony V. D’Amico, Judd Moul, Peter R. Carroll, Leon Sun, Deborah Lubeck, Ming-Hui Chen, Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era Journal of Clinical Oncology. ,vol. 21, pp. 2163- 2172 ,(2003) , 10.1200/JCO.2003.01.075